Table 4:

Survival Analyses Examining Conversion to Alzheimer’s Disease Stratified by Gender

Men (N=1337)
	B	SE	p	HR	95% HR CI
Step 1
Race	−.20	.26	.43	.82	.49–1.36
Step 2
Race	−.21	.27	.43	.81	.48–1.36
APOE e4	1.03	.13	<.001	2.80	2.19–3.58
Education	.01	.01	.10	1.01	1.00–1.03
Baseline Age	−.13	.01	<.001	.88	.86-.90
Diabetes	.24	.18	.17	1.27	.90–1.80
Hypertension	−.03	.13	.80	.97	.74–1.26
Referral Source	.86	.13	<.001	2.36	1.85–3.02
Women (N=2397)
	B	SE	p	HR	95% CI for HR
Step 1
Race	−.21	.16	.18	.81	.59–1.10
Step 2
Race	−.31	.17	.07	.74	.53–1.02
APOE e4	1.07	.11	<.001	2.92	2.34–3.66
Education	−.00	.01	.92	1.00	.98–1.02
Baseline Age	−.11	.01	<.001	.90	.88-.92
Diabetes	.09	.17	.61	1.09	.78–1.54
Hypertension	.30	.13	.02	1.35	1.05–1.74
Referral Source	.83	.12	<.001	2.30	1.81–2.91